Nothing Special   »   [go: up one dir, main page]

AT344883B - METHOD FOR OBTAINING INTRAVENO-COMPATIBLE GAMMAGLOBULIN - Google Patents

METHOD FOR OBTAINING INTRAVENO-COMPATIBLE GAMMAGLOBULIN

Info

Publication number
AT344883B
AT344883B AT981675A AT981675A AT344883B AT 344883 B AT344883 B AT 344883B AT 981675 A AT981675 A AT 981675A AT 981675 A AT981675 A AT 981675A AT 344883 B AT344883 B AT 344883B
Authority
AT
Austria
Prior art keywords
intraveno
gammaglobulin
compatible
obtaining
obtaining intraveno
Prior art date
Application number
AT981675A
Other languages
German (de)
Other versions
ATA981675A (en
Original Assignee
Plasmesco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco Ag filed Critical Plasmesco Ag
Publication of ATA981675A publication Critical patent/ATA981675A/en
Application granted granted Critical
Publication of AT344883B publication Critical patent/AT344883B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT981675A 1975-01-02 1975-12-23 METHOD FOR OBTAINING INTRAVENO-COMPATIBLE GAMMAGLOBULIN AT344883B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (en) 1975-01-02 1975-01-02 Process for the production of intravenously tolerated gamma globulins

Publications (2)

Publication Number Publication Date
ATA981675A ATA981675A (en) 1977-12-15
AT344883B true AT344883B (en) 1978-08-10

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT981675A AT344883B (en) 1975-01-02 1975-12-23 METHOD FOR OBTAINING INTRAVENO-COMPATIBLE GAMMAGLOBULIN

Country Status (20)

Country Link
JP (1) JPS5512001B2 (en)
AT (1) AT344883B (en)
AU (1) AU505416B2 (en)
BE (1) BE837211A (en)
CA (1) CA1058075A (en)
DD (1) DD121875A5 (en)
DE (1) DE2500076C3 (en)
DK (1) DK144679C (en)
EG (1) EG11987A (en)
ES (1) ES443982A1 (en)
FR (1) FR2296429A1 (en)
GB (1) GB1495159A (en)
IE (1) IE43449B1 (en)
IL (1) IL48766A (en)
IN (1) IN143525B (en)
NL (1) NL179824C (en)
PL (1) PL99599B1 (en)
SE (1) SE437470B (en)
SU (1) SU576898A3 (en)
ZA (1) ZA758050B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2936047A1 (en) * 1978-09-19 1980-03-27 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISIBLE ANTIBODY-IMMUNAL GLOBULIN PREPARATION AND PREPARATIONS PRODUCED THEREFORE

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
JPS6016406B2 (en) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル Method for producing intravenously administrable gamma globulin and gamma globulin prepared thereby
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (en) * 1977-07-19 1983-05-06 株式会社ミドリ十字 Intravenous gamma globulin preparations
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (en) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (en) * 1983-05-02 1984-11-03 Pharmacia Ind PROCEDURE FOR PURIFICATION OF BIOLOGICALLY ACTIVE SUBSTANCES
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (en) * 1999-02-21 2000-09-14 Bernd Horst Meier Means for controlling the diffusion of injection solutions
DE10040707A1 (en) * 2000-08-17 2002-03-14 Braun Melsungen Ag Injectable aqueous medicament, containing colloid, e.g. hydroxyethyl starch, to modulate mobility, diffusion, pharmacokinetic and electrophoretic properties of active agent and improve effectiveness
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
CA2631195C (en) 2005-11-30 2016-04-05 Abbott Laboratories Monoclonal antibodies against amyloid beta protein and uses thereof
KR20080090408A (en) 2005-11-30 2008-10-08 아보트 러보러터리즈 Anti-abeta; globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
MX360403B (en) 2010-04-15 2018-10-31 Abbvie Inc Amyloid-beta binding proteins.
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (en) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (en) * 1971-07-16 1973-02-08 South African Inventions METHOD OF MANUFACTURING A PURIFIED GAMMA GLOBULIN
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (en) * 1973-01-13 1974-09-25

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2936047A1 (en) * 1978-09-19 1980-03-27 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISIBLE ANTIBODY-IMMUNAL GLOBULIN PREPARATION AND PREPARATIONS PRODUCED THEREFORE
US4276283A (en) 1978-09-19 1981-06-30 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of preparing an intravenously administrable immune globulin preparation containing antibodies and preparations produced according to this method
DK154267B (en) * 1978-09-19 1988-10-31 Immuno Ag PROCEDURE FOR THE PREPARATION OF AN INTRAVENOST SUBMITTED ANTIBODY-IMMUNOGLOBULIN AND PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING THIS

Also Published As

Publication number Publication date
PL99599B1 (en) 1978-07-31
IE43449L (en) 1976-07-02
IL48766A0 (en) 1976-02-29
NL7514627A (en) 1976-07-06
SE437470B (en) 1985-03-04
AU505416B2 (en) 1979-11-22
ATA981675A (en) 1977-12-15
DK144679B (en) 1982-05-10
SE7514388L (en) 1976-07-05
CA1058075A (en) 1979-07-10
DE2500076B2 (en) 1979-02-22
DE2500076A1 (en) 1976-07-08
JPS5512001B2 (en) 1980-03-29
ZA758050B (en) 1976-12-29
EG11987A (en) 1981-12-31
DE2500076C3 (en) 1982-11-18
DK584375A (en) 1976-07-03
DD121875A5 (en) 1976-09-05
DK144679C (en) 1982-10-11
IL48766A (en) 1979-11-30
BE837211A (en) 1976-06-30
AU8792175A (en) 1977-07-14
ES443982A1 (en) 1977-07-16
SU576898A3 (en) 1977-10-15
IN143525B (en) 1977-12-17
IE43449B1 (en) 1981-02-25
FR2296429B1 (en) 1978-12-01
NL179824B (en) 1986-06-16
NL179824C (en) 1986-11-17
JPS5191321A (en) 1976-08-10
FR2296429A1 (en) 1976-07-30
GB1495159A (en) 1977-12-14

Similar Documents

Publication Publication Date Title
AT352510B (en) PROCESS FOR OBTAINING PROTEIN
AT344883B (en) METHOD FOR OBTAINING INTRAVENO-COMPATIBLE GAMMAGLOBULIN
DD131128A5 (en) METHOD FOR DE CCOUNTING OF COFFEE
DD128404A5 (en) PROCESS FOR FIXING PROTEINS TO TRAITERS
DD131022A5 (en) PROCESS FOR REDUCING CEPHALOSPORINSULFOXIDES
AT345252B (en) METHOD FOR MANUFACTURING MAGNETOXIDS
AT351672B (en) METHOD FOR OBTAINING IV-COMPATIBLE GAMMAGLOBULINES
ATA49278A (en) METHOD FOR THE HYDROFORMYLATION OF ALFA- -OLEFINES
AT349015B (en) METHOD FOR OBTAINING NICOTINIC ACID
AT354652B (en) METHOD FOR OBTAINING ZEARALENON
AT359489B (en) METHOD FOR PRODUCING INDOLE CONNECTIONS
AT358722B (en) METHOD FOR OBTAINING ARISTOLOCHIAS ACIDS
AT365074B (en) METHOD FOR OBTAINING HUMANALBUMIN
AT354966B (en) METHOD FOR FORMING BIOPROTEINS
DD133966A1 (en) METHOD FOR STABILIZING KAELTEMASCHINENOEL-KAELTEMITTELGEMISCHEN
AT369013B (en) METHOD FOR PRODUCING AMIDINOPHOSPHONATES
AT364369B (en) METHOD FOR OBTAINING CYANURCHLORIDE
DD138828A1 (en) METHOD FOR TESTING AD-TRANSFORMERS
DD161124A3 (en) METHOD FOR OBTAINING GLUCOSEISOMERASE
AT366934B (en) METHOD FOR COATING SURFACES
AT364371B (en) METHOD FOR OBTAINING CYANURCHLORIDE
AT364370B (en) METHOD FOR OBTAINING CYANURCHLORIDE
ATA811277A (en) PROCESS FOR DEBROMING 11A-BROMOM-6-DEMETHYL-6-DEOXY-6-METHYLEN-5-OXYTETRACYCLINE-SULFOSALICYLATE
PT67130B (en) METHOD FOR THE FLASH-MOORING OF FLORTEPPICHEN
AT362219B (en) METHOD FOR DECAFFINATING COFFEE